// App-Quantinova.ai

302 : Circulating biomarkers of sorafenib efficacy in advanced HCC.

Researchers

Presenter

  • Leonidas Chelis

Principal Investigators

  • Kostantinos Anagnostopoulos

  • Grigorios Trypsianis

  • Dimitrios Matthaios

  • Filio Koukaki

  • Alexandros H. Kortsaris

  • Stylianos Kakolyris

  • Eleni Kyrillos Hamalidou

  • Nikolaos Xenidis

  • Kiriakos Amarantidis

  • Savas Deftereos

  • Dimitra Pitsiava

  • Prodromos Michailidis

  • Evagelos Christakidis

  • Dimitrios Michailidis

Medical Centers

  • University General Hospital of Alexandroupoli, Alexandroupoli, Greece

  • Department of Medical Oncology, University Hospital of Alexandroupoli, Alexandroupoli, AZ, Greece

  • First Department of Internal Medicine, Democritus University of Thrace, Alexandroupolis, Greece

  • Democritus University of Thrace, Alexandroupoli, Greece

  • Democritus University of Thrace, Alexandroupoli, Greece

  • Second Department of Surgery, Democritus University of Thrace, Alexandroupolis, Greece

  • Laboratory of Statistics, Democritus University of Thrace, Alexandroupolis, Greece

  • Department of Medical Oncology, University Hospital of Alexandroupoli, Alexandroupoli, AZ, Greece

Locations

  • Greece

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Alpha-fetoprotein

  • Hepatocyte growth factor

  • Interleukin 6

  • Interleukin-8

  • Stromal cell-derived factor 1

  • Thrombospondin-1

  • Vascular endothelial growth factor A

  • Vascular Endothelial Growth Factor C

Drug/Treatment

  • Sorafenib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved